A carregar...
Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer
When treating patients with unresectable stage III non-small-cell lung cancer (NSCLC), those with a good performance status and disease measured within a radical treatment volume should be considered for definitive concurrent chemoradiotherapy (cCRT). This guidance is based on key scientific rationa...
Na minha lista:
| Publicado no: | Br J Cancer |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7735212/ https://ncbi.nlm.nih.gov/pubmed/33293671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-01070-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|